Description
From the marketplace listing
Rhizome is an AI Regulatory Coworker that researches comprehensively to answer based on facts it can directly tie to >130 indexed health authority databases.
Our customers are leveraging it to:
- Build regulatory strategies
- Understand clinical expectations
- Keep an eye on competitive intel
- Write and review HA-facing documents
Our datasets cover:
- FDA: drug, biologic and device approvals (Drugs@FDA, Purple Book, Orange Book, 510(k)/De Novo, PMA), DailyMed labels, guidance (including product-specific guidance), advisory committees, CRLs, warning and untitled letters, 483s and inspections, recalls, orphan designations, clinical trials, the CFR and the Federal Register
- EMA and EU: EPARs, guidelines, committee documents, orphan and PIP decisions, CTIS and EU CTR trials, EudraLex, MDCG guidance, EUDAMED devices and certificates
- UK MHRA, Health Canada, Swissmedic, TGA (Australia) and BfArM/PEI (Germany): approvals and assessment reports, guidance, regulations and clinical trials
- International standards: ICH, IMDRF, PIC/S, ISO and GHWP
- US market access: CMS coverage decisions, HCPCS codes and Part B drug pricing
- Competitive context: SEC filings, patents and PTAB decisions, PubMed, and RAPS/DIA regulatory news
Enterprise accounts can also search 50+ more databases, all translated to English:
- Japan PMDA: review reports, guidance, the Japanese Pharmacopoeia, and jRCT/UMIN clinical trials
- China NMPA/CDE: product reviews, CDE acceptances, guidance, regulations, announcements and consultations, clinical trials (including ChiCTR), and human genetic resources rules
- South Korea MFDS: review reports, drug, biologic and device regulations, guidance, notifications and clinical trials
- Brazil ANVISA: guidance, legislation, clinical research guidance and CONEP resolutions
- Taiwan TFDA/CDE: guidance, announcements, drug safety communications, regulatory notices and drug/device laws
- More jurisdictions: Argentina ANMAT, India CDSCO, South Africa SAHPRA, Saudi SFDA, Türkiye TİTCK, Israel MoH and UAE EDE
- FDA adverse events: FAERS (drugs) and MAUDE (devices)
- Health Canada: clinical study reports through PRCI
Support: support@rhizomeai.com